Globus Medical (GMED) Misses Q4 EPS by 3c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.49, $0.03 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $211.7 million versus the consensus estimate of $210.44 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
• Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance